AG
VRTX icon

AmeriFlex Group’s Vertex Pharmaceuticals VRTX Stock Holding History

AmeriFlex Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9K Sell
26
-161
-86% -$71.4K 0.01% 795
2026
Q1 		$83.5K Buy
187
+21
+13% +$9.79K 0.04% 320
2025
Q4 		$75.3K Sell
166
-26
-14% -$11.2K 0.04% 342
2025
Q3 		$75.2K Buy
192
+138
+256% +$57.7K 0.03% 384
2025
Q2 		$23.9K Buy
54
+26
+93% +$12K 0.01% 537
2025
Q1 		$13.6K Buy
28
+18
+180% +$8.39K 0.01% 768
2024
Q4 		$4.62K Buy
+10
New +$4.63K ﹤0.01% 927

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AmeriFlex Group's VRTX Position: Q2 2026 in Review

AmeriFlex Group reduced its Vertex Pharmaceuticals (VRTX) stake by 86% in Q2 2026, selling an estimated $71.4K and leaving 26 shares worth $12.9K. The position accounts for 0.01% of the portfolio, ranked #795.

AmeriFlex Group first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $83.5K in Q1 2026. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • AmeriFlex Group held 26 shares of Vertex Pharmaceuticals worth $12.9K as of Q2 2026.
  • AmeriFlex Group sold 161 Vertex Pharmaceuticals shares in Q2 2026, an estimated $71.4K.
  • Vertex Pharmaceuticals made up 0.01% of AmeriFlex Group's portfolio in Q2 2026, its #795 holding.
  • AmeriFlex Group first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • AmeriFlex Group's Vertex Pharmaceuticals position peaked at $83.5K in Q1 2026.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.